glp-1 market news november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Receptor Agonist Market Size

Discussion of Table 1: Table 1 synthesizes available data on formulary access for Wegovy (a representative weight-loss GLP-1) under the top PBMs, plus a note on general employer plans

"Building muscle increases your metabolism, helping you burn calories even when resting

Efficacy and safety of glp-1 receptor agonists and sglt-2 inhibitors in the treatment of diabetes mellitus and obesity in liver transplant recipients: a systematic review

Over the years, researchers have followed this drug to see who it harms in certain organ systems and haven't seen any significant red flags in the heart or blood vessels [7]

What happens if my medication concentration changes

Shares of Gland Pharma Ltd ended at 1,498.50, up by 14.35, or 0.97%, on the BSE